Fenwick Represents Dark Horse Consulting in Acquisition of BioTechLogic

Fenwick represented Dark Horse Consulting Group (“DCH”), a longstanding strategic and operational advisor in the field of cell and gene therapy (“CGT”), in its acquisition of BioTechLogic, a recognized forerunner in technical operations, manufacturing, quality and chemical, manufacturing and controls regulatory consulting.

This acquisition marks a significant milestone in Dark Horse Consulting’s growth, combining the complementary strengths of both teams while further consolidating DCH’s position at the vanguard of CGT. More information can be obtained from Dark Horse Consulting’s announcement.

The Fenwick team included corporate partners Eric Shedlosky, Victoria Lupu and Dawn Belt and associates Jordan Beals, Matt Reiser and Tempestt Edward; technology transactions partner Joseph Schenck and associate Alberto Tohme; executive compensation and employee benefits partner Nancy Chen and associates Jonathan Stephenson and Melita Chan; tax partner Mike Knobler and associate Einav Axler; and privacy and cybersecurity counsel Melanie Jolson.